- Meet Consumers/Patients
Baxter International, Inc., has announced the commercial launch of Hylenex recombinant (hyaluronidase human injection) for use in pediatric rehydration. Hylenex, an enzyme, allows fluids to be administered under the skin (subcutaneously) rather than through a vein. This may be an option for children who need hydration in whom IV access is an issue and in whom enteral nutrition will not work.
2/18/2017 » 2/21/2017
Oley exhibit at A.S.P.E.N.'s Clinical Nutrition Week
Oley Regional Conference